FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileTrulieve Cannabis Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
TRLV
Trulieve Cannabis Corp. Stock AnalysisComprehensive stock analysis for Trulieve Cannabis Corp. (TRLV) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisTRLV
TRLV
Trulieve Cannabis Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
TRLV
  1. Home
  2. Stocks
  3. Trulieve Cannabis Corp.

Trulieve Cannabis Corp.

🇺🇸TRLV•NYSE

Trulieve Cannabis Corp.

🇺🇸TRLV•NYSE
Market cap
$1.71B

Your view on TRLV

Mkt Cap
$1.71B
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Trulieve Cannabis Corp.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Kimberly A. Rivers
Headquarters
3494 Martin Hurst Road, Tallahassee, FL, US
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Kimberly A. Rivers
Headquarters
3494 Martin Hurst Road, Tallahassee, FL, US
Description

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery.

The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Trulieve Cannabis Corp.. Starting points for Trulieve Cannabis Corp.: EPS -$2.31, beta 1.92 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Trulieve Cannabis Corp.. Trailing twelve-month EPS for Trulieve Cannabis Corp. stands at -$2.31. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 20, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$15.00

average of analysts' targets

 

$15.00

Low $15.00

Median $15.00

High $15.00

 

Analyst Ratings

Buy1 rating
  • Strong Buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2024Next QtrMar 2025Current YearFY Dec 2024Next YearFY Dec 2025
Avg. estimate−$0.22−$0.07−$0.67−$0.43
Low estimate−$0.23−$0.08−$0.69−$0.44
High estimate−$0.22−$0.07−$0.66−$0.42
No. of analysts1112
Year-ago EPS————
Growth————

Revenue Estimate

RevenueCurrent QtrDec 2024Next QtrMar 2025Current YearFY Dec 2024Next YearFY Dec 2025
Avg. estimate$292.49M$294.28M$1.18B$1.19B
Low estimate$288.16M$289.92M$1.17B$1.18B
High estimate$297.50M$299.32M$1.20B$1.19B
No. of analysts4332
Year-ago revenue————
Growth————
Recent analyst actions4 rating and price-target changes, latest Nov 2, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Trulieve Cannabis Corp.. Trulieve Cannabis Corp. has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold TRLV12 companies · 8 funds
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
CANNTrees CorporationHealthcareOTC$4.1M
CANQFCanaQuest Medical Corp.HealthcareOTC$6.6M
CATV4Cable TV International, Inc.HealthcareOTC$865,619
CBDDCBD of Denver Inc.HealthcareOTC$980,918
CBDHFHempfusion Wellness Inc.HealthcareOTC$1,635
CBDLCBD Life Sciences Inc.HealthcareOTC$375,394
CBDXCurative Biosciences, Inc.HealthcareOTC$51,578
CBDYTarget Group Inc.HealthcareOTC$863,836
CBGLCannabis Global, Inc.HealthcareOTC$28,410
CBIHCannabis Bioscience International Holdings, Inc.HealthcareOTC$5.2M
CBSTFThe Cannabist Company Holdings Inc.HealthcareNYSE$14.5M
CBWTFAuxly Cannabis Group Inc.HealthcareOTC$121.4M
ETFs holding Trulieve Cannabis Corp.
TickerFundFund assets% of the fund
MSOSAdvisorShares Pure US Cannabis ETF$793M in assets38.54%
VXFVanguard Extended Market ETF$30.2B in assets0.02%
VTIVanguard Total Stock Market ETF$689.2B in assets0.00%
CNBSAmplify Seymour Cannabis ETF$64M in assets16.79%
SCHASchwab U.S. Small-Cap ETF$21.7B in assets0.04%
FYCFirst Trust Small Cap Growth AlphaDEX Fund$1.4B in assets0.49%
YOLOAdvisorShares Pure Cannabis ETF$30M in assets16.50%
FYXFirst Trust Small Cap Core AlphaDEX Fund$1.4B in assets0.23%

Largest holders first, then the funds most concentrated in TRLV.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Trulieve Cannabis Corp., and how their positions are changing. At a $1.71B market value, institutional positions materially move Trulieve Cannabis Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Trulieve Cannabis Corp. executives and directors. Shares of Trulieve Cannabis Corp. have traded between $4.62 and $13.28 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Trulieve Cannabis Corp.. Coverage tracks Trulieve Cannabis Corp. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Trulieve Cannabis Corp.

TRLV AnalysisFair
Past
5
Growth
2
Health
3
Profit
1
Value
1

News

Latest Market News